212 related articles for article (PubMed ID: 12442190)
1. [Atherosclerosis in HIV-positive patients].
Neumann T; Miller M; Esser S; Gerken G; Erbel R
Z Kardiol; 2002 Nov; 91(11):879-88. PubMed ID: 12442190
[TBL] [Abstract][Full Text] [Related]
2. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
3. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
[TBL] [Abstract][Full Text] [Related]
4. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
Barbaro G
Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function in HIV-infected patients with low or mild cardiovascular risk.
Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ
J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of HIV cardiac disease.
Cotter BR
Prog Cardiovasc Dis; 2003; 45(4):319-26. PubMed ID: 12638095
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
9. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
10. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
12. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
Calza L; Manfredi R; Chiodo F
J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac manifestations in HIV-infected individual].
Neumann T; Ross B; Hengge UR; Gerken G; Erbel R
Med Klin (Munich); 2002 Nov; 97(11):659-65. PubMed ID: 12434274
[TBL] [Abstract][Full Text] [Related]
15. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery disease and human immunodeficiency virus infection.
Passalaris JD; Sepkowitz KA; Glesby MJ
Clin Infect Dis; 2000 Sep; 31(3):787-97. PubMed ID: 11017831
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
19. [HIV infection: emerging issues and new challenges].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736
[TBL] [Abstract][Full Text] [Related]
20. [Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors].
Gurgo AM; Massino Ferri F; Iulianella R; Luciani C; Lucifero A; Staropoli P; Rocchi M
Ital Heart J Suppl; 2001 Nov; 2(11):1236-9. PubMed ID: 11775417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]